Table of Contents

Global Anal and Colorectal Cancer Market Outlook-by Major Company, Regions, Type, Application and Segment Forecast, 2016-2027
1 Market Scope Anal and Colorectal Cancer
1.1 Anal and Colorectal Cancer Market Snapsshot
1.1.1 Major Companies Overview
1.1.2 Market Concentration
1.1.3 Market Share & Six-Year Compound Annual Growth Rate of Major Market (CAGR)
2 Global Anal and Colorectal Cancer Industry Analysis
2.1 Sector Breakdown Assessment, 2016-2027
2.2 Market Assessment by Type
2.3 Market Size Analysis and Forecast, by Application
3 China Anal and Colorectal Cancer Market Estimates & Forecasts
3.1 China Anal and Colorectal Cancer Market by Sector, 2015-2026
3.2 China Anal and Colorectal Cancer Market by Application, 2016-2027
4 EU Anal and Colorectal Cancer Market Estimates & Forecasts
4.1 EU Anal and Colorectal Cancer Market by Sector, 2016-2027
4.2 EU Anal and Colorectal Cancer Market by Application, 2016-2027
5 USA Anal and Colorectal Cancer Market Estimates & Forecasts
5.1 USA Anal and Colorectal Cancer Market by Sector, 2016-2027
5.2 USA Anal and Colorectal Cancer Market by Application, 2016-2027
6 Japan Anal and Colorectal Cancer Market Estimates & Forecasts
6.1 Japan Anal and Colorectal Cancer Market by Sector, 2016-2027
6.2 Japan Anal and Colorectal Cancer Market by Application, 2016-2027
7 India Anal and Colorectal Cancer Market Estimates & Forecasts
7.1 India Anal and Colorectal Cancer Market by Sector, 2016-2027
7.2 India Anal and Colorectal Cancer Market by Application, 2016-2027
8 Southeast Asia Anal and Colorectal Cancer Market Estimates & Forecasts
8.1 Southeast Asia Anal and Colorectal Cancer Market by Sector, 2016-2027
8.2 Southeast Asia Anal and Colorectal Cancer Market by Application, 2016-2027
9 South America Anal and Colorectal Cancer Market Estimates & Forecasts
9.1 South America Anal and Colorectal Cancer Market by Sector, 2016-2027
9.2 South America Anal and Colorectal Cancer Market by Application, 2016-2027
10 Value Chain (Impact of COVID-19)
10.1 Anal and Colorectal Cancer Value Chain Analysis
10.1.1 Downstream
10.2 COVID-19 Impact on this Industry
10.2.1 Industrial Policy Issued Under the Epidemic Situation
10.3 Driver
10.4 Opportunity

11 Competitive Analysis
11.1 Abbott Diagnostics
11.1.1 Key Information
11.1.2 Service/Solution Introduction
11.1.3 Financials
11.1.4 Business Dynamics
11.2 Advaxis
11.2.1 Key Information
11.2.2 Service/Solution Introduction
11.2.3 Financials
11.2.4 Business Dynamics
11.3 Abbott
11.3.1 Key Information
11.3.2 Service/Solution Introduction
11.3.3 Financials
11.3.4 Business Dynamics
11.4 Amgen
11.4.1 Key Information
11.4.2 Service/Solution Introduction
11.4.3 Financials
11.4.4 Business Dynamics
11.5 Atara Biotherapeutics
11.5.1 Key Information
11.5.2 Service/Solution Introduction
11.5.3 Financials
11.5.4 Business Dynamics
11.6 Bayer
11.6.1 Key Information
11.6.2 Service/Solution Introduction
11.6.3 Financials
11.6.4 Business Dynamics
11.7 Metabiomics
11.7.1 Key Information
11.7.2 Service/Solution Introduction
11.7.3 Financials
11.7.4 Business Dynamics
11.8 Beckman Coulter
11.8.1 Key Information
11.8.2 Service/Solution Introduction
11.8.3 Financials
11.8.4 Business Dynamics
11.9 BeiGene
11.9.1 Key Information
11.9.2 Service/Solution Introduction
11.9.3 Financials
11.9.4 Business Dynamics
11.10 Boehringer Ingelheim
11.10.1 Key Information
11.10.2 Service/Solution Introduction
11.10.3 Financials
11.10.4 Business Dynamics
11.11 Clinical Genomics
11.12 EDP Biotech
11.13 Eli Lilly
11.14 Epigenomics
11.15 Exact Sciences
11.16 Genomictree
11.17 Immunovaccine
11.18 ISA Pharmaceuticals
11.19 Merck
12 Research Conclusion

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.